TECLens is hiring. Please visit https://teclens.com/careers/ TECLens is leading the transformation of refractive vision care. The company has developed a novel, incisionless technology called quantitative corneal crosslinking or qCXLTM that can reshape your cornea without laser-ablation or invasive surgery. qCXLTM may be used to free presbyopic patients from the need for reading glasses, to prevent children from developing high myopia and to treat keratoconus. We believe our platform technology will revolutionize the existing standard of care for these eye care conditions. TECLens goal is to make our simple, cost-effective procedure the primary choice for patients seeking refractive correction, improving vision for millions of patients around the world. We are a young, emerging growth company with an entrepreneurial culture using a collaborative approach in all that we do. We are looking for talented and success-oriented people to join our team.